Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial. - Huang, Tao; Hu, Qianqian; Zhou, Xiang; Yang, Huaiyu; Xia, Wei; Cao, Feng; Deng, Minglu; Teng, Xiaoxue; Ding, Fan; Zhong, Zaixin; Gao, Lidong; Sun, Jiufeng; et al. (BMC Infectious Diseases, 2024)